Forover 100 years, Remington has been the definitive textbook and reference on the science and practice of pharmacy. This Twenty-First Edition keeps pace with recent changes in the pharmacy curriculum and professional pharmacy practice.
More than 95 new contributors and 5 new section editors provide fresh perspectives on the field. New chapters include pharmacogenomics, application of ethical principles to practice dilemmas, technology and automation, professional communication, medication errors, re-engineering pharmacy practice, management of special risk medicines, specialization in pharmacy practice, disease state management, emergency patient care, and wound care.
For more than 100 years and through 19 previous editions, Remington The Science and Practice of Pharmacy has long been the standard book and reference for pharmacists, and now this new edition is even better. The reader will find a work with more orientation towards pharmaceutical practice, maintaining its traditionally reliable scientific context. This 20th edition is a "refresher course" in all aspects of pharmacy, from personal and institutional conduct to manufacturing, research and development of pharmaceuticals. The text is more objective, with less reference material, which can become obsolete in a short time. This edition emphasizes pedagogical principles while providing essential references to the source material.
Allen M. Kratz, PharmD is the founder of HVS Laboratories, a registered homeopathic medicine manufacturer, providing pure water-based formulations to health care professionals; the same mission for twenty five years. He explored the depths of both conventional and complementary medicine in his lifetime. He was a pharmacy professor when he became the first pharmacist to serve on the Editorial Board of The Merck Manual.
Allen received his BSc and MSc degrees in Pharmacy from the Philadelphia College of Pharmacy and Science. After receiving a MSc in Radiological Health from Temple University, he returned to PCP&S to serve on its faculty. His Doctor of Pharmacy degree was conferred in 1968. Academically, Dr. Kratz is affiliated with two universities.
His interest in complementary medicine was piqued in the 1970's and he quickly became fond of the principles of homeopathy. He became a renowned author, contributor and columnist in the areas of complementary medicine, pharmacy and homeopathy.
He is a Clinical Assistant Professor of Pharmacy Practice at the Medical University of South Carolina, College of Pharmacy and also a Clinical Assistant Professor in the Department of Medicine at the College of Osteopathic Medicine, Nova Southeastern University in Ft. Lauderdale, Florida.
Dr. Kratz was a contributor, editor or author of several professional reference texts including Remington's Practice of Pharmacy (14th and 15th editions) and the United States Dispensatory (27th edition). He was appointed to the Editorial Board of The Merck Manual (12th edition) as the first pharmacist to serve in that capacity. He was a board member for the 13th edition as well. Currently, Dr. Kratz serves as co-editor of the Journal of the American Nutraceutical Association (JANA) and was recently appointed editor of a new book titled Nutraceuticals and Pharmaceuticals: An Integrative Approach to be published by CRC Press LLC.
He is a member of Advisory Boards to the International Academy of Nutrition and Preventive Medicine, The Society of Natural Pharmacy and the American Nutraceutical Association. He is also the co-author of a chapter on Complementary Health Care in the 19th and new 20th editions of Remington: The Science and Practice of Pharmacy and is a frequent contributor to professional publications and peer-reviewed journals.
"Community/outpatient pharmacy" means an established place in which prescriptions, drugs, medicines, chemicals, and poisons are prepared, compounded, dispensed, vended, distributed, or sold to or for the use of nonhospitalized patients and from which related pharmaceutical care services are provided. Practitioners, as defined in Minnesota Statutes, section 151.01, subdivision 23, dispensing prescription drugs to their own patients in accordance with parts 6800.9950 to 6800.9954 are not included within this definition.
"Community satellite" means a site affiliated with a licensed community pharmacy, which is dependent on the licensed community pharmacy for administrative control, staffing, and drug procurement. A community satellite must be under the direction of a licensed pharmacist and comply with the requirements of part 6800.0800, subpart 3.
"Expiration date" means the date placed on the container or label of a drug product designating the time during which the product is expected to remain within the approved shelf life specifications if stored under defined conditions, and after which it may not be used.
"Hospital pharmacy" means an established place located in a licensed hospital in which prescriptions, drugs, medicines, chemicals, and poisons are prepared, compounded, dispensed, vended, distributed, or sold to hospitalized patients and from which related pharmaceutical care services are delivered.
"Hospital satellite" means a site in a licensed hospital, which is not physically connected with the centrally licensed pharmacy, but is within the same facility or building and is dependent on the centrally licensed pharmacy for administrative control, staffing, and drug procurement. A hospital satellite must be under the direction of a licensed pharmacist, comply with the requirements of part 6800.0800, subpart 3, and provide pharmacy services to hospital patients only.
"Long-term care pharmacy" means an established place, whether or not in conjunction with a hospital pharmacy or a community/outpatient pharmacy, in which prescriptions, drugs, medicines, chemicals, or poisons are prepared, compounded, dispensed, vended, distributed, or sold on a regular and recurring basis to or for the use of residents of a licensed nursing home, boarding care home, assisted living facility, or supervised living facility and from which related pharmaceutical care services are delivered.
For the purposes of this chapter, the term "assisted living facility" means a registered housing with services establishment, as defined in Minnesota Statutes, section 144D.01, subdivision 4, that provides central storage of medications for residents.
"Nuclear pharmacy" is an area, place, or premises described in a license issued by the board with reference to plans approved by the board where radioactive drugs are stored, prepared, manufactured, derived, manipulated, compounded, or dispensed and from which related clinical services are provided.
"Home health care pharmacy" means an established place, whether or not in conjunction with a hospital pharmacy, long-term care pharmacy, or a community/outpatient pharmacy, in which parenteral or enteral drugs or medicines are prepared, compounded, and dispensed for the use of nonhospitalized patients and from which related pharmaceutical care services are provided.
"Pharmaceutical care" means the responsible provision of drug therapy and other pharmaceutical patient care services by a pharmacist intended to achieve definite outcomes related to the cure or prevention of a disease, the elimination or reduction of a patient's symptoms, or the arresting or slowing of a disease process.
"Prescription drug order" means a lawful written, oral, or electronic order of a practitioner for a drug for a specific patient. A prescription drug order must contain the information specified in this chapter and in Minnesota Statutes, section 151.01, subdivision 16.
"Prescription" means a prescription drug order that is written or printed on paper, an oral order reduced to writing by a pharmacist, or an electronic order. To be valid a prescription must be issued for an individual patient by a practitioner within the scope and usual course of the practitioner's practice, and must contain the date of issue, name and address of the patient, name and quantity of the drug prescribed, directions for use, the name and address of the practitioner, and a telephone number at which the practitioner can be reached. A prescription written or printed on paper that is given to the patient or an agent of the patient, or transmitted facsimile-to-facsimile must contain the practitioner's manual signature. An electronic prescription must contain the practitioner's electronic signature.
"Chart order" means a prescription drug order for a drug that is to be dispensed by a pharmacist, or by a pharmacist-intern under the direct supervision of a pharmacist, and administered by an authorized person only during the patient's stay in a hospital or long-term care facility. The chart order shall contain the name of the patient, another patient identifier such as a birth date or medical record number, the drug ordered, and any directions as the practitioner may prescribe concerning strength, dosage, frequency, and route of administration. The manual or electronic signature of the practitioner must be affixed to the chart order at the time it is written or at a later date in the case of verbal chart orders.
"Nonsterile preparation compounding" means the preparation, mixing, assembling, altering, packaging, and labeling of a nonsterile drug preparation, according to United States Pharmacopeia Chapter 795.
"Sterile preparation compounding" means the preparation, mixing, assembling, altering, packaging, and labeling of a drug preparation that achieves sterility, according to United States Pharmacopeia Chapter 797.
Whenever an applicable rule requires or prohibits action by a pharmacy, responsibility for said action shall be that of the owner and pharmacist-in-charge thereof, whether said owner is a sole proprietor, partnership, association, corporation, or otherwise.
Applications for the licensing of a pharmacy and renewal thereof shall be on such form or forms as the Board of Pharmacy may from time to time prescribe, and the license of such pharmacy shall be issued by the Board of Pharmacy in such form as it may from time to time prescribe.
3a8082e126